Prenetics Global (PRE) EBITDA Margin (2021 - 2026)
Prenetics Global's (PRE) quarterly EBITDA Margin came in at 45.13% in Q2 2026, up 2655.0% year-over-year from 1.64% in Q2 2025, and down 189.77% quarter-over-quarter from 15.57% in Q1 2026.
Analysis
Prenetics Global (PRE) EBITDA Margin (2021 - 2026) Analysis & Trends
Prenetics Global (PRE) has reported EBITDA Margin for 6 consecutive years, with 45.13% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin rose 2655.0% year-over-year to 45.13% in Q2 2026; TTM through Jun 2026 was 24.82%, a 8336.0% increase from a year earlier, with the FY2025 full-year figure at 0.78%, down 657.0% from the prior year.
- EBITDA Margin was 45.13% for Q2 2026 at Prenetics Global, down from 15.57% in the prior quarter.
- Over five years, EBITDA Margin peaked at 0.6% in Q1 2022 and troughed at 2320.98% in Q4 2022.
- A 5-year average of 341.93% and a median of 187.12% in 2024 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin sank 186887 bps in 2022 and surged 135976 bps in 2023, its largest moves.
- Over 5 years, EBITDA Margin stood at 2320.98% in 2022, then surged by 59 bps to 961.22% in 2023, then surged by 81 bps to 187.12% in 2024, then surged by 97 bps to 5.52% in 2025, then sank by 718 bps to 45.13% in 2026.
- The last three EBITDA Margin figures came in at 45.13% (Q2 2026), 15.57% (Q1 2026), and 5.52% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | 13.96% |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 25.82% |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | -27.93% |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | 1.38% |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | -41.90% |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | -71.11% |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | 10.83% |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | - |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn | -45.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -45.13% |
| Mar 31, 2026 | -15.57% |
| Dec 31, 2025 | -5.52% |
| Sep 30, 2025 | -26.17% |
| Jun 30, 2025 | -71.67% |
| Mar 31, 2025 | -29.47% |
| Dec 31, 2024 | -187.12% |
| Sep 30, 2024 | -269.76% |
| Mar 31, 2024 | -142.83% |
| Dec 31, 2023 | -961.22% |
| Sep 30, 2023 | -265.29% |
| Jun 30, 2023 | -228.07% |
| Mar 31, 2023 | -302.42% |
| Dec 31, 2022 | -2,320.98% |
| Sep 30, 2022 | -396.18% |
| Jun 30, 2022 | -544.72% |
| Mar 31, 2022 | -0.60% |
| Dec 31, 2021 | -452.11% |
| Sep 30, 2021 | -7.15% |
| Jun 30, 2021 | 18.75% |